Tissium
PrivateLast Round
Debt
Jun 24, 2026
Total Funding Raised
$302.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tissium is a France-based medtech company that develops a platform of biomorphic programmable polymers for tissue reconstruction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tissium Comparables
Compare Tissium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regenity Biosciences | 80% | |
| BioCircuit Technologies | 78% | |
| Orthocell Ltd | 77% |
Tissium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 24, 2026 | ||||
| Series D Extension | Dec 31, 2025 | ||||
| Series D Extension | Dec 1, 2025 | ||||
| Series D | May 23, 2023 | ||||
| Series C | Aug 31, 2021 | ||||
Series B | Nov 20, 2019 |
Key People
Founding team and executive leadership
Tissium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series D Extension, Series D |
| BNP Paribas Développement | Series B |
| CapDecisif Management | Series A Extension, Series B, Series A |
| ISALT | Series D |
| European Investment Fund | Series B |
| European Investment Bank Group | Debt |
| Crédit Mutuel Innovation | Series A Extension, Series B, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 47% MoM.
- Mar 18, 2026
Tissium is actively exploring the expansion of its TISSIUM platform into new applications, including nerve repair.
Recent news
Latest coverage and updates
- receives_financingJul 31, 2026
Tissium SA received financing of $57.7M in Series D on Jul 31st '26.
- identified_as_competitor_ofJun 24, 2026
Tissium SA identified as competitor of BioCircuit Technologies.
- receives_financingJun 24, 2026
Tissium received financing of $34.3M in Series D2 on Dec 31st '25.
Tissium Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tissium's valuation, stock price, and market status.
Is Tissium a public or private company?
Tissium is a private company.
What is the current stock price of Tissium?
Tissium is a private company with no public stock price. No recent secondary market data is available.
How much is Tissium worth (valuation)?
Valuation information for Tissium is not publicly available.
Can I buy Tissium stock?
Tissium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tissium's last funding round?
Tissium's most recent funding round was Series D Extension on December 1, 2025.
Who are the main investors in Tissium?
Key investors in Tissium include Bpifrance, Sofinnova Partners, Omnes Capital.
Will Tissium IPO soon?
No public IPO plans have been announced for Tissium.
How can I track Tissium secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tissium's secondary market activity and sign up for updates.